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Summary 
A  synthetic tetrasaccharide  structurally related  to  blood  groups  and  sdectin  ligands  inhibited 
division of astrocytes, gliomas, and neuroblastomas at rnicromolar concentrationi The compound was 
cytostatic for primary astrocytes in culture, but cytotoxic for fast proliferating cell lines. 
I 
n the mammalian central nervous system (CNS), astroglial 
cell division during adulthood and old age remains more 
a potentiality than a frequent event (1). It was long suspected 
that mitogen inhibitors may play a crucial role in the control 
of astrocyte populations and, previously, we presented evi- 
dence  that  an  antimitotic,  immunologically  related  to 
epidermal growth factor receptor (EGFR), inhibited prolifer- 
ation of rat astrocytes in primary culture (2). Astrocyte prolifer- 
ation after open CNS injury correlated with a decrease in 
the activity of this antimitotic, suggesting that the inhibitor 
was involved in the physiological control of astrocyte number. 
The following evidence suggested that the active moiety of 
the antimitotic is glycosidic in nature. Immunoglobulins from 
human blood group O, as well as a mAb to a carbohydrate 
epitope of EGFR crossreacting with blood group A  (anti- 
body 29.1; reference 3), blocked antimitotic activity (4). Diges- 
tion of  brain antimitotic with ~-ghcosidase or ~-ghcuronidase 
destroyed the inhibitory activity (J.  Abad and M.  Nieto- 
Sampedro, unpublished observations). HnaUy, a common sugar 
component of blood groups, t-Fucose (Fuc), had weak an- 
timitotic  activity  (IDs0  --  35  mM;  reference  4).  We 
hypothesized that oligosaccharides with structure related to 
that of blood groups, may be cell division inhibitors. To test 
this idea we synthesized (a) fucosyl-lactoses; (b) the trisac- 
charide best recognized by antibody 29.1 (11); and (c) a tetrasac- 
charide that combined the structural features of the best trisac- 
charide inhibitors.  The restdts of testing their ability to inhibit 
the division of both astrocytes in primary culture and trans- 
formed neural cells,  are the subject of this report. 
Materials and Methods 
Synthetic Compounds, Cell Culture; [~H]thymidine  Incorporation, and 
Cell Viability.  Synthesis  of oligosaccharide and primary cultures 
of purified rat astrocytes, were performed as described previously 
(5-7). All cells were maintained in a 1:1 mixture of DMEM and 
Ham's F12 (Sigma Chemical Co., St. Louis, MO), supplemented 
with 10'/o (vol/vol) FCS (2, 4). 
Incorporation of [3H]thymidine into primary cultures of rat as- 
trocytes  (and its  inhibition),  was  measured using  the 96-well 
microassay previously described (2). The data are the mean and 
SEM of three independent experiments each performed in tripli- 
cate. Control incorporation in the absence of antimitotic  sugar 
ranged from 6,000 to 12,000 dpm/well for astrocytes and RN22 
cells (7) to 19,000 dpm/well for A7 cells. Addition of serum was 
not necessary for the cell lines A7 astrocytoma (8) and Neuro-2a 
ueuroblastoma (9) to incorporate [3H]thymidine. The concentra- 
tions of antimitotic that inhibited [3H]thymidine  incorporation by 
50% (IDs0), were obtained from dose-response curves (see Fig. 1). 
Cell viability was determined at inhibitor concentrations above the 
IDs0 value, as described by Jones and Senft (10). 
Results and Discussion 
Immunoglobulins from human blood group O and a mono- 
clonal anti-EGFR that crossreacted with blood group A (11), 
blocked rat brain antimitotic activity (3). A common blood 
group constituent, L-Fucose (Fuc), was weakly antimitotic 
(IDs0  =  35 raM). Taken together, these data suggested that 
the natural brain antimitotic could be structurally related 
to blood  group  sugars  (4).  Accordingly, the trisaccharide 
best recognized by monoclonal 29.1, N-acetylgalactosaminyl- 
lactose (11) and three fucosyl-lactoses, were synthetized (5, 
6), and their antimitotic activity examined. All fucosyl-lactoseg 
as  well  as  N-acetylgalactosaminy-lactose, were inhibitory 
(Table  1). 
Relating the structure of the trisaccharide: 
C~-D-GalNAc-(1-~3)-~-D-Gal-(1-*4)-D-Glc 
to that of the most inhibitory fucosyllactose: 
~-D-Gal-(1-~4)-D-Glc 
1'1-3 
ol-r-Fuc 
we hypothesized that the tetrasaccharide: 
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Volume  176  September  1992  915-918 Table  1.  Carbohydrate Inhibition of [~H1thymidine Incorporation in Astrocytes 
Carbohydrate  structure 
L-Fucose  L-Fuc 
2'-FucosyUactose  ~-D-GaI-(1--~4)-D-Glc 
tl-2 
Ot-L-Fuc 
3,2'-DifucosyUactose  /3-D-Gal-(  1--*4-D-Glc 
tl-2  1'1-3 
Ol-t-Fuc  Cr 
3-FucosyUactose  ~-D-Gal-(1--*4)-D-GIc 
tl-3 
OL-L-Fuc 
Trisaccharide  O~-D-GalNAc-(  1--*-3)-3-D-Gal-(  1-*4)-~-D-Glc-Me 
Tetrasaccharide  O~-D-GalNAc-(  1-*-3)-~-D-Gal-(1--4)-~-D-Glc-Me 
tl-3 
OL-L-Fuc 
ID~ 
mM 
35.0 
7.8 
6.4 
4.3 
0.235 
0.076 
*IDs0 estimated  as indicated  in Materials and Methods. [3H]thymidine  incorporation  in the absence  of antimitotic sugar ranged  from 8,000 to 12,000 
dpm/well. 
Ot-D-GalNAc-(1--*3)-fl-D-Gal-(1--*4)-D-Glc 
i'1-3 
Ot-L-Fuc 
structurally related to blood groups A and Lewis X, and re- 
ferred to as TS4, would be a better antimitotic than any of 
the trisaccharides. 
Ot-D-GalNAc-(I~3)-B-D-Gal-(I~4)-[C~-L-Fuc-(1---*3)]-B-D- 
GlcMe, was synthesized (6) and its antimitotic activity tested 
on cultures of neonatal rat astrocytes, A7 astrocytoma (8), 
Neuro-2a neuroblastoma (9), and ILN22 Schwannoma (7). 
A dose-dependent inhibition of thymidine incorporation was 
observed,  with 50% inhibition (IDs0) in the/zM range (Fig. 
1 and Table 1). All cells were viable at the ID50, indicating 
that growth inhibition did not involve cytotoxicity. In fact, 
cell death was never observed with astrocytes or tLN22 ceils, 
even at doses of TS4 that totally blocked thymidine incorpo- 
ration. However, a large proportion of fast dividing cells of 
lines A7 and Neuro-2a were not viable after 24-h contact 
with TS4 concentrations between 0.5 and 1.0 mM (Fig.  1, 
percent  viability).  Therefore,  selective  destruction  of fast 
proliferating cells appears  possible. 
Some structure-activity conclusions may be drawn from 
the IDs0 values  in Table  1 and Fig.  1.  Thus,  although fu- 
cose itself inhibited astrocyte division, its presence in oligosac- 
charides was not essential for antimitotic activity (see N-acetyl- 
galactosaminy-lactose, Table 1). N-acetylgalactosamine seemed 
more important when the target cells were primary astro- 
cytes, whereas fucose substitution conferred oligosaccharides 
higher antimitotic effectiveness on fast proliferating cells, rel- 
ative to primary cultures. It contributed to make TS4 three 
times more potent than N-acetylgalactosarniny-lactose  on pri- 
mary astrocytes, but 13 times more potent on transformed 
Neuro-2a cells (Fig.  1). 
Known ligands  of selectins,  a class  of Ca2+-dependent 
lectins that contain EGF domains, contain a carbohydrate 
moiety similar to TS4 (12). Previously, we reported that an 
inhibitor of astrocyte division present in rat brain shared a 
carbohydrate epitope with EGFK (2).  Our present results 
suggest that the active site of the natural EGFK-related an- 
timitotic may be related to synthetic TS4.  Compared with 
TS4,  glycoconjugates have N-acetylglucosamine instead of 
glucose.  Hence,  a  structure  C~-D-GalNAc(1-~3)-~-D-Gal- 
(1-~)-[Ot-L-Puc-(1-*3)]-fl-D-GlcNAc, containing the 3-fucosyl- 
N-acetyllactosamine (FAL) epitope (13), may be more similar 
to the natural regulators of cell division. A  similar group, 
sialyl-Lewis  X  (SiI~)  seems involved in both normal and 
tumoral cell proliferation (14-16).  Furthermore, it has been 
proposed that interaction of SiLe  x with the sdectin endo- 
thelial leukocyte adhesion molecule-1 (ELAM-1) may lead to 
extravasation of tumoral cells, thus mediating metastasis (17). 
Although fucose and sialic  add are required for ELAM-1 
binding (18), the effect of a GalNAc instead of sialic acid was 
not tested. Synthetic TS4 analogues would be antimetastatic 
if they could compete with the natural ligand for the ELAM-1 
binding site. 
Although blood  group  carbohydrate groups  have  been 
known for a long time, their biological role was never estab- 
lished.  Inhibition  of cell division by blood  group-related 
oligosaccharides, suggests that these substances may be in- 
volved in controlling cell proliferation. Blood group-related 
carbohydrates, also involved in cell adhesion, could underlie 
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Figure 1.  Dose-response  curves  for the antimitotic  activity 
of (--O-), the trisaccharide o~-n-GalNAc-(1--*3)-fl-n-Gal- 
(1-,-4)-fl-n-Glc-Me, and (-4b-), the tetrasaccharide Oe-n- 
GalNAc-(1-~3)-fl-D-Gal-(l~4)-[c~-t-Fuc-(1-~3)]-B-n-Glc-Me. 
Percent values  indicate  percent viability.  All data  are the mean 
_+ SEM of three independent  experiments, each performed 
in triplicate. 
contact inhibition of cell growth. The identification of a syn- 
thetic structure capable of inhibiting fast proliferating tumoral 
cells, raises the possibility of controlling pathological cell di- 
vision and has practical importance. Most brain tumors are 
gliomas, and preliminary results in a rat model indicate that 
TS4 can arrest their growth. 
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